Recent Finacing
Recent Raise
NewStem operates a precision-medicine platform using human haploid embryonic stem cells and genetic screens to catalog chemotherapy-resistance mutations and predict patient tumor drug resistance.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at NewStem.
